[1] MAHESWARI RAJASEKARAN . Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors[J]. Toxicology and applied pharmacology, 2013, 269 2: Pages 100-108. DOI:
10.1016/j.taap.2013.03.012[2] XINGXING DIAO Marilyn A H. New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites.[J]. Frontiers in Chemistry, 2019, 7: 109. DOI:
10.3389/fchem.2019.00109[3] RALPH ADERORHO Shadrack W L, CHRISTOPHER D. CHOUINARD* Separation and Characterization of Synthetic Cannabinoid Metabolite Isomers Using SLIM High-Resolution Ion Mobility-Tandem Mass Spectrometry (HRIM-MS/MS)[J]. Journal of the American Society for Mass Spectrometry, 2024, 35 3: 582-589. DOI:
10.1021/jasms.3c00419[4] RUI SHEN ONG. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography–tandem mass spectrometry – A New Zealand perspective of use in 2018[J]. Drug Testing and Analysis, 2019, 12 2: 195-214. DOI:
10.1002/dta.2697 
